With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Emerging technologies are proving that small molecules aren't yesterday's news.